⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30876713 | 1.00 | — | — | |
| SCHEMBL30876744 | 1.00 | — | — | |
| SCHEMBL20215623 | 0.83 | — | — | |
| SCHEMBL2913301 | 0.83 | GBA1 (0.33) | — | |
| SCHEMBL1190914 | 0.81 | — | — | |
| SCHEMBL5696915 | 0.81 | — | — | |
| SCHEMBL197631 | 0.81 | — | — | |
| SCHEMBL2908604 | 0.81 | FDPS (0.38) | — | |
| SCHEMBL891139 | 0.79 | — | — | |
| SCHEMBL1010137 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030087981-A1 | Floor finish compositions | 3M INNOVATIVE PROPERTIES COMPANY | 2003-05-08 | — | — | US | claimed |
| US-6197844-B1 | Floor finish compositions | 3M INNOVATIVE PROPERTIES COMPANY | 2001-03-06 | — | — | US | claimed |
| EP-0929612-A1 | FLOOR FINISH COMPOSITIONS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1999-07-21 | — | — | EP | claimed |
| WO-1998011168-A1 | FLOOR FINISH COMPOSITIONS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-03-19 | — | — | WO | claimed |
| US-9375423-B2 | Use of aminoindane compounds in treating overactive bladder and interstitial cystitis | ASANA BIOSCIENCES, LLC (US) | 2016-06-28 | — | — | US | disclosed |
| US-20150290182-A1 | USE OF AMINOINDANE COMPOUNDS IN TREATING OVERACTIVE BLADDER AND INTERSTITIAL CYSTITIS | ASANA BIOSCIENCES, LLC (US) | 2015-10-15 | — | — | US | disclosed |
| US-9044482-B2 | Use of aminoindane compounds in treating overactive bladder and interstitial cystitis | ASANA BIOSCIENCES, LLC (US) | 2015-06-02 | — | — | US | disclosed |
| US-8865741-B2 | Aminoindane compounds and use thereof in treating pain | ASANA BIOSCIENCES, LLC (US) | 2014-10-21 | — | — | US | disclosed |
| US-20140051702-A1 | Use of Aminoindane Compounds in Treating Overactive Bladder and Interstitial Cystitis | ENDO PHARMACEUTICALS INC. (US) | 2014-02-20 | — | — | US | disclosed |
| US-20120214809-A1 | Aminoindane Compounds and Use Thereof in Treating Pain | Libertas Bio, Inc. | 2012-08-23 | — | — | US | disclosed |
| CN-1196751-C | Floor finish compositions | MINNESOTA MINING & MFG (US) | 2005-04-13 | — | — | CN | disclosed |
| US-6780472-B2 | POLYFUNCTIONAL ISOCYANURATE HAVING AT LEAST THREE TERMINAL REACTIVE GROUPS REACTED WITH HYDROXYALKYL ACRYLATE AND TERTIARY AMINE ALCOHOL | 3M INNOVATIVE PROPERTIES COMPANY | 2004-08-24 | — | — | US | disclosed |
| US-20030087981-A1 | Floor finish compositions | 3M INNOVATIVE PROPERTIES COMPANY | 2003-05-08 | — | — | US | disclosed |
| WO-2002092578-A1 | QUINAZOLINE DERIVATIVES | ASTRAZENECA AB (SE) | 2002-11-21 | — | — | WO | disclosed |
| WO-2002092577-A1 | QUINAZOLINE DERIVATIVES | ASTRAZENECA AB (SE) | 2002-11-21 | — | — | WO | disclosed |
| US-6197844-B1 | Floor finish compositions | 3M INNOVATIVE PROPERTIES COMPANY | 2001-03-06 | — | — | US | disclosed |
| CN-1229423-A | Floor finish compositions | MINNESOTA MINING & MFG (US) | 1999-09-22 | — | — | CN | disclosed |
| EP-0929612-A1 | FLOOR FINISH COMPOSITIONS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1999-07-21 | — | — | EP | disclosed |
| WO-1998011168-A1 | FLOOR FINISH COMPOSITIONS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-03-19 | — | — | WO | disclosed |